COMPANY

Oblenio Bio

Keywords: immunology autoimmune diseases

Location: Lexington, MA · source · Oct 12, 2026

Profile checked Oct 10, 2026

Raises and deals from press releases

Raise Series B · $62M · announced Jun 25, 2026 Company release ↗
Source quote
- Jun 25, 2026 · Company release ↗
  “Oblenio Bio Closes $62 Million Series B to Advance Tri-specific T-Cell Engager LBL-051 for Autoimmune Diseases into Clinical Development -- Round led by Pfizer Ventures”

Raises announced in these releases: $62M disclosed.

From the company’s own releases; this list is partial. All raises and deals